^
Association details:
Evidence:
Evidence Level:
Sensitive: C3 – Early Trials
Source:
Title:

Aldehyde Dehydrogenase 2 Family Member (ALDH2) Is a Therapeutic Index for Oxaliplatin Response on Colorectal Cancer Therapy with Dysfunction p53

Published date:
02/07/2022
Excerpt:
...low expression of ALDH2 is correlated with poor overall survival and oxaliplatin resistance. In conclusion, we demonstrate that ALDH2 may be a biomarker for oxaliplatin resistance status in CRC patients...
DOI:
https://doi.org/10.1155/2022/1322788